Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 31722-852

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 31722-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan20mg30scontainerlabel (Olmesartan20mg30scontainerlabel)

Olmesartan20mg30scontainerlabel (Olmesartan20mg30scontainerlabel)
Label for Olmesartan Medoxomil tablets, USP, 20 mg strength, film-coated oral tablets, packaged in a bottle of 30 tablets. The label includes the NDC 31722-853-30 and is manufactured for Camber Pharmaceuticals, Inc. Storage instructions recommend room temperature (20 to 25°C). Manufacturer details list Hetero Labs Limited in India.*
FDA Label Image

Olmesartan40mg30scontainerlabel (Olmesartan40mg30scontainerlabel)

Olmesartan40mg30scontainerlabel (Olmesartan40mg30scontainerlabel)
Label for Olmesartan Medoxomil 40 mg film-coated tablets by Camber Pharmaceuticals, Inc. This prescription oral tablet packaging indicates 30 tablets per container. The label states storage instructions, a U.S. contact number, and manufacturing by Hetero Labs Limited in India. A barcode and NDC 31722-854-30 appear on the label.*
FDA Label Image

Olmesartan5mg30scontainerlabel (Olmesartan5mg30scontainerlabel)

Olmesartan5mg30scontainerlabel (Olmesartan5mg30scontainerlabel)
Label for Olmesartan Medoxomil Tablets, USP 5 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label states a package quantity of 30 tablets and includes storage instructions and manufacturing details, including that it is manufactured for Camber Pharmaceuticals in Piscataway, NJ, and by Hetero Labs Limited in India.*
FDA Label Image
FDA Label Image

Olmesartanfigure1 (Olmesartanfigure1)

Olmesartanfigure1 (Olmesartanfigure1)
A line graph showing the dose response of Olmesartan Medoxomil tablets in reducing blood pressure, measured in mmHg. The X-axis represents the dose of Olmesartan Medoxomil tablets in mg from 0 to 100 mg. The Y-axis shows the reduction in blood pressure. Two lines plot the reduction: one with circular markers for systolic blood pressure and one with triangular markers for diastolic blood pressure, indicating both decrease as the dose increases.*
FDA Label Image

Olmesartanstructure (Olmesartanstructure)

Olmesartanstructure (Olmesartanstructure)
Chemical structure of olmesartan medoxomil, the active ingredient shown in the image consists of multiple rings, esters, and nitrogen-containing moieties representing its molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.